Bridgeway Capital Management’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$197K Sell
24,582
-418
-2% -$3.13K ﹤0.01% 1023
2026
Q2
$174K Buy
+25,000
New +$148K ﹤0.01% 1085
2021
Q3
– Sell
-111,600
Closed -$1.41M – 1308
2021
Q2
$1.41M Sell
111,600
-25,000
-18% -$275K 0.03% 740
2021
Q1
$1.77M Hold
136,600
– – 0.03% 662
2020
Q4
$459K Buy
+136,600
New +$513K 0.01% 979

Other funds holding EOLS

Bridgeway Capital Management's EOLS Position: Q3 2026 in Review

Bridgeway Capital Management reduced its Evolus (EOLS) stake by 1.7% in Q3 2026, selling an estimated $3.13K and leaving 24,582 shares worth $197K. The position accounts for ﹤0.01% of the portfolio, ranked #1023.

Bridgeway Capital Management first reported a position in EOLS in Q4 2020 and has held it in 5 quarters since. The position peaked at $1.77M in Q1 2021. 170 funds tracked by Wall St. Rank hold EOLS as of Q3 2026.

  • Bridgeway Capital Management held 24,582 shares of Evolus worth $197K as of Q3 2026.
  • Bridgeway Capital Management sold 418 Evolus shares in Q3 2026, an estimated $3.13K.
  • Evolus made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q3 2026, its #1023 holding.
  • Bridgeway Capital Management first reported a position in Evolus in Q4 2020 and has held it in 5 quarters since.
  • Bridgeway Capital Management's Evolus position peaked at $1.77M in Q1 2021.
  • 170 funds tracked by Wall St. Rank held Evolus as of Q3 2026.

Based on Bridgeway Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.